Opportunity Information: Apply for CDC RFA CK11 11060501SUPP16
Apply for CDC RFA CK11 11060501SUPP16
- The Department of Health and Human Services, Centers for Disease Control - NCEZID in the health sector is offering a public funding opportunity titled "CDC Mexico Co-Ag for Surveillance & Epidemiology" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283.
- This funding opportunity was created on Aug 19, 2016.
- Applicants must submit their applications by Oct 18, 2016 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $5,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The CDC Mexico Co-Ag for Surveillance and Epidemiology grant opportunity (CDC RFA CK11 11060501SUPP16) is a discretionary cooperative agreement run by the U.S. Department of Health and Human Services through CDCs National Center for Emerging and Zoonotic Infectious Diseases (NCEZID). It was created in August 2016 with an application closing date in October 2016, and it anticipated making a single award (while listing a broader ceiling). The specific scope described in the Statement of Work centers on a USAID/CDC interagency agreement (IAA) for FY2016 called "La Vivienda Segura / The Healthy Household," designed as an educational and surveillance intervention model in Mexico to prevent mosquito-borne infections (especially Zika) and sexually transmitted infections that can affect reproductive health, pregnancy, and outcomes in the perinatal period. The activity was negotiated through NCEZID/DGMQ, with a stated IAA end date of December 31, 2018, and a planned implementation period of two years from the date funds were obligated.
The rationale for the award is rooted in the rapid spread of Zika virus across the Americas beginning in 2015 and the escalating evidence linking Zika infection during pregnancy with severe congenital outcomes, including microcephaly and other brain abnormalities. Because Mexico was expected to experience significant Zika transmission and shares a highly trafficked land border with the United States, the opportunity positions Mexico as strategically important for early detection, monitoring, and response. The overall intent is to strengthen Mexican public health readiness by supporting partners in epidemiology, enhanced surveillance, laboratory diagnosis, and prevention, with a special emphasis on surveillance in pregnant women and follow-up of infants and children.
Funding in the described scope totals USD 553,312 in new extramural obligations from Washington sources, with no U.S. government full-time equivalents (0 FTEs) assigned. The implementation approach relies on an existing CDC cooperative agreement with FUMEC (Fundacion Estados Unidos Mexico para la Ciencia; award CK000191), a binational nonprofit created in the NAFTA context that manages U.S.-Mexico science and public health projects. Under this structure, FUMEC would subcontract with the Autonomous University of Yucatan, including the Regional Research Institute "Hideyo Noguchi," to carry out on-the-ground activities in coordination with the CDC Mexico office (Mexico City) and CDC subject matter experts as needed. The work is also described as leveraging local capacity and ongoing efforts, including an existing dengue vaccine clinical trial platform with long-term follow-up, potential complementary funding from Mexicos CONACYT, and strong political support from Yucatan state health authorities. International technical collaborations are noted with the Institute of Tropical Medicine in Antwerp and the Pedro Kouri Institute in Havana, and a separate mobile-app component includes partners such as the Skoll Foundation and the University of Arizona.
Program objectives are organized around three main goals. First, the project aims to implement communication and community education strategies that are explicitly gender-sensitive, combining mosquito-bite prevention and vector-control education with family planning counseling for women and men of reproductive age, including pregnant women and their partners. Second, it seeks to enhance public health surveillance for pregnant women, emphasizing early detection of infections that can affect mother and child, including syphilis, HIV, dengue (DENV), chikungunya (CHIKV), and Zika (ZIKV). Third, it intends to strengthen laboratory capacity to detect Zika infection in pregnant women, aligning diagnostics with surveillance and clinical follow-up to better characterize risks and outcomes.
A major cross-cutting feature of the opportunity is its emphasis on gender considerations as central to effective Zika prevention and response. The Statement of Work highlights that gender roles, decision-making power within households, access to contraception, education and literacy, early marriage patterns, and intersecting inequities (such as ethnicity, socioeconomic status, and age) can shape exposure risk, prevention behaviors, and access to services. As a result, communication campaigns and materials are expected to be synchronized across populations (consistent core information) while still being contextualized to maximize comprehension and relevance for different groups of women and men.
The workplan is broken into four activities with defined deliverables and acceptance targets, most notably a recurring benchmark of community acceptance or reach of at least 70 percent for key outreach tools. Activity 1 focuses on implementing a gender-sensitive awareness and education campaign using diverse educational materials, including mobile phone apps, to teach prevention of mosquito bites and the potential sexual transmission of Zika among reproductive-age men and women and their families. The community intervention is anchored in Merida, Yucatan, particularly the colonias Juan Pablo II and Los Vergeles, with additional work in a high-risk community in Progreso, Yucatan. This activity connects education to practical prevention actions such as distribution of repellents, household and community vector control practices under the "Safe Housing" model, and workshops that integrate contraception (including condoms), family planning options, and nutrition counseling to support healthier conception and pregnancy. The stated budget for this activity is USD 126,952, and its success is tied to educational activities reaching at least 70 percent of the targeted population.
Activity 2 is centered on procurement of supplies needed to detect Zika and other vector-borne viruses and to support enhanced surveillance of pregnant women. The intent is not only operational (ensuring testing and surveillance can function) but also analytic: adding evidence on the association between maternal Zika infection and adverse pregnancy and infant outcomes, exploring possible mechanisms, and identifying pregnant women at higher risk for poor outcomes. This activity also describes longer-term post-birth surveillance of children exposed in utero to assess outcomes that may not be obvious at delivery, and it proposes developing a database of biological specimens and laboratory results that is unlinked to surveillance data, suggesting a structure aimed at protecting privacy while enabling laboratory-based research or quality monitoring. The activity budget is listed in a range or with multiple figures (noted as USD 264,000 and USD 341,000 in the text), but it is clearly the largest cost component of the four activities.
Activity 3 addresses workforce capacity by training and cross-training laboratory personnel, ultrasound and prenatal diagnosis specialists, and neuro-epidemiologists and developmental specialists, with support from CDC subject matter experts. The goal is to build reliable antenatal diagnostic capability for Zika-related brain abnormalities and to improve classification and assessment of adverse pregnancy and infant outcomes. Performance is framed in operational terms such as reducing the time to correct diagnosis of antenatal infection and the time to correct classification of outcomes. This training component has a comparatively small budget of USD 27,500, but it is positioned as essential for making surveillance and laboratory investments clinically meaningful.
Activity 4 introduces a participatory surveillance and risk-communication mobile app for Android and iPhone that prompts users to respond weekly about symptoms and daytime mosquito bites. The app is intended to let users see aggregated community data and confirmed Zika cases mapped geographically, supporting both public awareness and planning, and helping connect residents with local public health resources. This activity expands beyond Yucatan by referencing community participation alongside public health authorities in Nogales (Sonora), Nuevo Laredo (Tamaulipas), and Merida (Yucatan), with collaborations that include CDC Atlanta (DGMQ/CDC), Mexican northern border states, and Mexicos CENAPRECE. The success indicator is again community acceptance and use at or above 70 percent, and the budget for this component is USD 57,860 (extramural). The app is described as already developed in English and slated for Spanish translation.
Taken together, the opportunity funds a tightly connected package: community education and behavior change (with explicit integration of reproductive health and condom-based prevention), strengthened surveillance focused on pregnant women and infant outcomes, upgraded laboratory and diagnostic capacity, targeted workforce training, and a digital tool for participatory surveillance and real-time health communication. The geographic emphasis on Yucatan (especially Merida) reflects existing arboviral risk patterns and available research infrastructure, while the inclusion of northern border locations in the app activity signals an interest in cross-regional situational awareness relevant to U.S.-Mexico public health coordination.
Frequently Asked Questions (FAQs)
What is the name and reference number of this grant opportunity?
The opportunity is described as the "CDC Mexico Co-Ag for Surveillance and Epidemiology" grant opportunity, referenced as CDC RFA CK11 11060501SUPP16.
What type of funding mechanism is it?
It is a discretionary cooperative agreement administered by the U.S. Department of Health and Human Services through the Centers for Disease Control and Prevention (CDC), specifically within the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID).
When was the opportunity created and when did applications close?
The opportunity was created in August 2016 and had an application closing date in October 2016.
How many awards were anticipated?
The opportunity anticipated making a single award (even though a broader ceiling was listed).
What is the core project described in the Statement of Work?
The scope centers on a USAID/CDC interagency agreement (IAA) for FY2016 titled "La Vivienda Segura / The Healthy Household." It is presented as an educational and surveillance intervention model in Mexico designed to prevent mosquito-borne infections (especially Zika) and sexually transmitted infections that can affect reproductive health, pregnancy, and perinatal outcomes.
Why was this project considered necessary?
The rationale is tied to the rapid spread of Zika virus across the Americas starting in 2015 and growing evidence linking Zika infection during pregnancy with severe congenital outcomes such as microcephaly and other brain abnormalities. Mexico is framed as strategically important due to expected Zika transmission and its highly trafficked land border with the United States, making early detection, monitoring, and response particularly relevant.
What is the overall intent of the award?
The intent is to strengthen public health readiness in Mexico by supporting work in epidemiology, enhanced surveillance, laboratory diagnosis, and prevention, with special emphasis on surveillance in pregnant women and follow-up of infants and children.
What is the total funding amount described?
The described scope totals USD 553,312 in new extramural obligations from Washington sources.
Were any U.S. government staff (FTEs) assigned to this effort?
No. The scope states that 0 U.S. government full-time equivalents (0 FTEs) were assigned.
Who is the primary implementing partner mentioned?
The implementation approach relies on an existing CDC cooperative agreement with FUMEC (Fundacion Estados Unidos Mexico para la Ciencia) under award CK000191. FUMEC is described as a binational nonprofit created in the NAFTA context that manages U.S.-Mexico science and public health projects.
How would the on-the-ground work be carried out?
Under the described structure, FUMEC would subcontract with the Autonomous University of Yucatan, including the Regional Research Institute "Hideyo Noguchi," to conduct local activities in coordination with the CDC Mexico office (Mexico City) and CDC subject matter experts as needed.
What existing platforms or complementary resources does the project plan to leverage?
The work is described as leveraging local capacity and ongoing efforts, including an existing dengue vaccine clinical trial platform with long-term follow-up, potential complementary funding from Mexico's CONACYT, and political support from Yucatan state health authorities.
What other technical collaborations are mentioned?
International technical collaborations are noted with the Institute of Tropical Medicine in Antwerp and the Pedro Kouri Institute in Havana. A separate mobile-app component mentions partners such as the Skoll Foundation and the University of Arizona.
What are the main program goals?
Objectives are organized around three main goals: (1) implement gender-sensitive communication and community education strategies that integrate mosquito-borne prevention and reproductive health counseling; (2) enhance surveillance for pregnant women with early detection of infections affecting pregnancy and infants; and (3) strengthen laboratory capacity to detect Zika in pregnant women and align diagnostics with surveillance and follow-up.
Which infections are specifically included in the enhanced surveillance focus?
The surveillance emphasis includes syphilis, HIV, dengue (DENV), chikungunya (CHIKV), and Zika (ZIKV).
How is gender addressed in the project design?
Gender considerations are described as central to effective Zika prevention and response. The scope highlights that gender roles, household decision-making power, contraception access, education and literacy, early marriage patterns, and intersecting inequities (including ethnicity, socioeconomic status, and age) can shape exposure risk, prevention behaviors, and access to services. Communication is expected to be synchronized (consistent core information) but contextualized for different groups of women and men to maximize comprehension and relevance.
How is the workplan structured?
The workplan is broken into four activities with defined deliverables and acceptance targets. A notable recurring benchmark is community acceptance or reach of at least 70 percent for key outreach tools.
What does Activity 1 cover?
Activity 1 focuses on implementing a gender-sensitive awareness and education campaign using diverse educational materials, including mobile phone apps, to teach prevention of mosquito bites and the potential sexual transmission of Zika among reproductive-age women and men and their families. It links education to practical prevention actions such as repellent distribution, household and community vector control under the "Safe Housing" model, and workshops integrating contraception (including condoms), family planning options, and nutrition counseling to support healthier conception and pregnancy.
Where is Activity 1 intended to be implemented?
The community intervention is anchored in Merida, Yucatan, specifically the colonias Juan Pablo II and Los Vergeles, with additional work in a high-risk community in Progreso, Yucatan.
What is the budget for Activity 1?
The stated budget for Activity 1 is USD 126,952.
What performance target is tied to Activity 1?
Success is tied to educational activities reaching at least 70 percent of the targeted population.
What does Activity 2 cover?
Activity 2 centers on procuring supplies needed to detect Zika and other vector-borne viruses and to support enhanced surveillance of pregnant women. It also aims to add evidence on the association between maternal Zika infection and adverse pregnancy and infant outcomes, explore possible mechanisms, identify higher-risk pregnant women, and support longer-term post-birth surveillance of children exposed in utero to detect outcomes that may not be obvious at delivery.
What does Activity 2 say about specimens and data handling?
It proposes developing a database of biological specimens and laboratory results that is unlinked to surveillance data, suggesting an approach intended to protect privacy while still enabling laboratory-based research or quality monitoring.
What is the budget for Activity 2?
The text lists multiple figures for Activity 2 (USD 264,000 and USD 341,000) and describes it as the largest cost component among the four activities.
What does Activity 3 cover?
Activity 3 focuses on workforce capacity by training and cross-training laboratory personnel, ultrasound and prenatal diagnosis specialists, and neuro-epidemiologists and developmental specialists, supported by CDC subject matter experts. The aim is to improve antenatal diagnostic capability for Zika-related brain abnormalities and strengthen classification and assessment of adverse pregnancy and infant outcomes.
How is performance described for Activity 3?
Performance is framed operationally, including reducing the time to correct diagnosis of antenatal infection and reducing the time to correct classification of outcomes.
What is the budget for Activity 3?
The budget for Activity 3 is USD 27,500.
What does Activity 4 cover?
Activity 4 introduces a participatory surveillance and risk-communication mobile app for Android and iPhone. The app prompts weekly user responses about symptoms and daytime mosquito bites, and it is intended to display aggregated community data and geographically mapped confirmed Zika cases to support public awareness, planning, and connections to local public health resources.
Where is the mobile app activity expected to be used?
It references participation alongside public health authorities in Nogales (Sonora), Nuevo Laredo (Tamaulipas), and Merida (Yucatan), indicating an interest beyond Yucatan for this component.
Which public health entities are referenced in connection with the app activity?
The activity references collaborations that include CDC Atlanta (DGMQ/CDC), Mexican northern border states, and Mexico's CENAPRECE.
What is the performance target for Activity 4?
The success indicator is community acceptance and use at or above 70 percent.
What is the budget for Activity 4?
The budget for Activity 4 is USD 57,860 (extramural).
What languages are mentioned for the mobile app?
The app is described as already developed in English and slated for Spanish translation.
What is the planned implementation period?
The planned implementation period is two years from the date funds were obligated.
What end date is stated for the USAID/CDC interagency agreement (IAA)?
The IAA end date is stated as December 31, 2018.
What is the geographic focus of the overall project?
The geographic emphasis is on Yucatan (especially Merida) due to arboviral risk patterns and existing research infrastructure, while the app activity also includes northern border locations (Nogales and Nuevo Laredo) to support cross-regional situational awareness relevant to U.S.-Mexico coordination.
What prevention methods are explicitly included in the intervention model?
The described package includes mosquito-bite prevention and vector-control education, household and community actions under the "Safe Housing" model, distribution of repellents, and reproductive health components such as family planning counseling and contraception education (including condoms), alongside nutrition counseling to support healthier conception and pregnancy.
How do the four activities fit together?
The opportunity funds a connected package that combines community education and behavior change (including reproductive health and condom-based prevention), strengthened surveillance focused on pregnant women and infant outcomes, upgraded laboratory and diagnostic capacity, targeted workforce training, and a mobile tool for participatory surveillance and real-time risk communication.
Browse more opportunities from the same category: Health
Next opportunity: Glacier Bay NP Backcountry/Wilderness Visitor Use Study
Previous opportunity: Panther Prey Research
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA CK11 11060501SUPP16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA CK11 11060501SUPP16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Protecting and Strengthening Public Health Impact, Systems, Capacity, and Security Apply for CDC RFA GH14 141802CONT17 Funding Number: CDC RFA GH14 141802CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Program Expansion Supplement: Supporting Laboratory Strengthening Activities in Resource-Limited Countries under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 13660301SUPP16 Funding Number: CDC RFA GH13 13660301SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $500,000 |
| Program Expansion Supplement: Supporting Laboratory Strengthening Activities in Resource-Limited Countries under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 13660302SUPP16 Funding Number: CDC RFA GH13 13660302SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,500,000 |
| Technical Assistance to Obtain State and Territorial Health Department Input for Health Care System and Hospital Preparedness Related Activities Apply for EP HIT 16 003 Funding Number: EP HIT 16 003 Agency: Department of Health and Human Services, Assistant Secretary for Preparedness and Response Category: Health Funding Amount: $500,000 |
| Communication For Improved Health Outcomes (CIHO) Apply for RFA 656 16 000015 Funding Number: RFA 656 16 000015 Agency: Agency for International Development, Mozambique USAID-Maputo Category: Health Funding Amount: $999,887 |
| Population-Based Surveillance of Birth Defects and Data Utilization for Public Health Action Apply for CDC RFA DD16 160102CONT17 Funding Number: CDC RFA DD16 160102CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - NCBDDD Category: Health Funding Amount: Case Dependent |
| Rape Prevention and Education Apply for CDC RFA CE14 140104CONT17 Funding Number: CDC RFA CE14 140104CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - NCIPC Category: Health Funding Amount: Case Dependent |
| STD/HIV Disease Intervention Services Training Centers (DISTC) National Center for HIV, Viral Hepatitis, STD and TB Prevention (NCHHSTP) Apply for CDC RFA PS14 140804CONT17 Funding Number: CDC RFA PS14 140804CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - NCHHSTP Category: Health Funding Amount: Case Dependent |
| SUPPORT FOR ORPHANS AND VULNERABLE CHILDREN (OVC) IN KENYA Apply for NOFO 615 16 000033 Funding Number: NOFO 615 16 000033 Agency: Agency for International Development Category: Health Funding Amount: $64,000,000 |
| Rural Health Research Dissemination Cooperative Agreement Apply for HRSA 17 002 Funding Number: HRSA 17 002 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Resilient and Responsive Health Organizations: Sustainability Communities of Practice Initiative (RRHO) Apply for HRSA 17 032 Funding Number: HRSA 17 032 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Engaging Youth and Young Adults from Health Disparity Populations in the HIV Treatment Cascade (R01) Apply for RFA MD 16 003 Funding Number: RFA MD 16 003 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $500,000 |
| Service Area Competition Apply for HRSA 17 054 Funding Number: HRSA 17 054 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Strengthening Ebola rapid detection and response capacity through community based surveillance and safe burial practices Apply for CDC RFA GH16 1722 Funding Number: CDC RFA GH16 1722 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Accountable Health Communities Track 1 - Awareness Apply for CMS 1P1 17 002 Funding Number: CMS 1P1 17 002 Agency: Department of Health and Human Services, Centers for Medicare Medicaid Services Category: Health Funding Amount: $1,170,000 |
| Developing Measures of Shared Decision Making (R01) Apply for PA 16 424 Funding Number: PA 16 424 Agency: Department of Health and Human Services, Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
| Rural Access to New Opportunities in Water, Sanitation, and Hygiene “RANO WASH Program†Apply for RFA 687 16 000007 Funding Number: RFA 687 16 000007 Agency: Agency for International Development, Madagascar USAID-Antananarivo Category: Health Funding Amount: $30,000,000 |
| Establishment of a Strategic Partnership to Strengthen the COMISCA Central America Region Apply for CDC RFA GH15 150903CONT17 Funding Number: CDC RFA GH15 150903CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Leadership Education in Adolescent Health (LEAH) Apply for HRSA 17 029 Funding Number: HRSA 17 029 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Building Capacity along the Continuum from Prevention to Care and Treatment for Key Populations in the Central America Region under the PEPFAR Central America Region Apply for CDC RFA GH15 151003CONT17 Funding Number: CDC RFA GH15 151003CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA CK11 11060501SUPP16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.